FDA Citizen Petition #1: DMF Carcinogen in Valsartan

On June 13, 2019, Valisure announced the detections of N, N-Dimethylformamide (“DMF”) in specific lots of the drug valsartan, an angiotensin II receptor blocker (“ARB”). DMF is a chemical that was reclassified in 2018 as a Group 2A probable human carcinogen by the World Health Organization (“WHO”) and the International Association for Research of Cancer (“IARC”).

Complete Valisure Citizen Petition Documents:

Media highlights:

FDA Citizen Petition #1: DMF Carcinogen in Valsartan

April 8, 2022

On June 13, 2019, Valisure announced the detections of N, N-Dimethylformamide (“DMF”) in specific lots of the drug valsartan, an angiotensin II receptor blocker (“ARB”). DMF is a chemical that was reclassified in 2018 as a Group 2A probable human carcinogen by the World Health Organization (“WHO”) and the International Association for Research of Cancer (“IARC”).

Complete Valisure Citizen Petition Documents:

Media highlights:

FDA Citizen Petition #1: DMF Carcinogen in Valsartan

On June 13, 2019, Valisure announced the detections of N, N-Dimethylformamide (“DMF”) in specific lots of the drug valsartan, an angiotensin II receptor blocker (“ARB”). DMF is a chemical that was reclassified in 2018 as a Group 2A probable human carcinogen by the World Health Organization (“WHO”) and the International Association for Research of Cancer (“IARC”).

Complete Valisure Citizen Petition Documents:

Media highlights:

On June 13, 2019, Valisure announced the detections of N, N-Dimethylformamide (“DMF”) in specific lots of the drug valsartan, an angiotensin II receptor blocker (“ARB”). DMF is a chemical that was reclassified in 2018 as a Group 2A probable human carcinogen by the World Health Organization (“WHO”) and the International Association for Research of Cancer (“IARC”).

Complete Valisure Citizen Petition Documents:

Media highlights:

SIGN UP FOR THE VALISURE NEWSLETTER 

Sign up to stay updated with Valisure announcements, relevant industry news, company updates, and more. 

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.